These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9419568)
1. Biodistribution and excretion of 153Gd-labeled gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid following repeated intravenous administration to rats. Mühler A; Weinmann HJ Acad Radiol; 1995 Apr; 2(4):313-8. PubMed ID: 9419568 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116 [TBL] [Abstract][Full Text] [Related]
3. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Tweedle MF; Wedeking P; Kumar K Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190 [TBL] [Abstract][Full Text] [Related]
4. Quantification of dechelation of gadopentetate dimeglumine in rats. Kasokat T; Urich K Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049 [TBL] [Abstract][Full Text] [Related]
5. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Saito S; Obata A; Kashiwagi Y; Abe K; Murase K Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774 [TBL] [Abstract][Full Text] [Related]
7. Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Sato T; Tamada T; Watanabe S; Nishimura H; Kanki A; Noda Y; Higaki A; Yamamoto A; Ito K Radiol Med; 2015 Jun; 120(6):557-62. PubMed ID: 25572545 [TBL] [Abstract][Full Text] [Related]
8. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Tsuda N; Okada M; Murakami T Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431 [TBL] [Abstract][Full Text] [Related]
9. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960 [TBL] [Abstract][Full Text] [Related]
11. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Mühler A; Heinzelmann I; Weinmann HJ Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100 [TBL] [Abstract][Full Text] [Related]
12. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
13. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. Lin CY; Chang WC; Chou CT; Chen RC J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212 [TBL] [Abstract][Full Text] [Related]
16. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats. Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694 [TBL] [Abstract][Full Text] [Related]
17. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate. Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394 [TBL] [Abstract][Full Text] [Related]
19. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. Kim T; Murakami T; Hasuike Y; Gotoh M; Kato N; Takahashi M; Miyazawa T; Narumi Y; Monden M; Nakamura H J Magn Reson Imaging; 1997; 7(4):683-8. PubMed ID: 9243389 [TBL] [Abstract][Full Text] [Related]
20. A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA. Murase K; Assanai P; Takata H; Saito S; Nishiura M Magn Reson Imaging; 2013 Dec; 31(10):1744-51. PubMed ID: 24094686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]